Suppr超能文献

通过再分散壳形成纳米粒子提高核壳结构珠的口服生物利用度:制备、表征和体内研究。

Improved oral bioavailability of core-shell structured beads by redispersion of the shell-forming nanoparticles: preparation, characterization and in vivo studies.

机构信息

Department of Pharmaceutics, Shenyang Pharmaceutical University, Wen Hua Road No. 103, Shenyang 110016, China.

School of Materials Science and Engineering, Xi'an Jiaotong University, China.

出版信息

Colloids Surf B Biointerfaces. 2014 Jan 1;113:92-100. doi: 10.1016/j.colsurfb.2013.08.037. Epub 2013 Sep 3.

Abstract

In order to increase the dissolution rate and oral bioavailability of bifendate, coated beads with core-shell structure were prepared via a combination use of wet media milling method and bead layering process. Hydroxypropyl cellulose (HPC-SL) and sodium lauryl sulfate (SLS) were found to be the best pair to stabilize the nanosuspension during milling process. A 10:1 ratio of mixture of mannitol and SLS was chosen as most suitable coating matrix to maintain the redispersability of dried nanoparticles in the shell of beads. The mean particle size of the nanosuspension was 139 nm and the zeta potential was -20.2 mV. Nanoscale bifendate particles with a mean diameter of 360 nm could be generated when redispersing the prepared beads in water. The differential scanning calorimetry (DSC) and X-ray powder diffraction (XRPD) analysis indicated that the crystalline state of the drug was not changed. The stability test confirmed that coated beads showed no distinct difference in particle size and dissolution velocity during 6 month storage while liquid nanosuspension was stable no more than 3 weeks. Dissolution rate of coated beads was increased significantly compared with commercially available pills. Likewise, the Cmax and AUC (0→24) of nanosuspension based beads in beagle dogs were 2.40-fold and 1.66-fold greater than that of commercially available pills, respectively. The present work is a reliable approach to stabilize nanosuspension based product, and improve dissolution velocity and bioavailability of poor soluble drugs.

摘要

为了提高双氯芬酸的溶解速率和口服生物利用度,采用湿磨法和丸芯层层上药法相结合的方法制备了具有核壳结构的包衣珠。研究发现羟丙基纤维素(HPC-SL)和十二烷基硫酸钠(SLS)是在研磨过程中稳定纳米混悬液的最佳组合。选择甘露醇和 SLS 的混合物以 10:1 的比例作为最适合的包衣基质,以保持纳米粒子在丸芯壳中的再分散性。纳米混悬液的平均粒径为 139nm,zeta 电位为-20.2mV。当将制备的丸芯重新分散在水中时,可得到平均直径为 360nm 的纳米双氯芬酸颗粒。差示扫描量热法(DSC)和 X 射线粉末衍射(XRPD)分析表明,药物的结晶状态没有改变。稳定性试验表明,在 6 个月的储存期内,包衣丸的粒径和溶出速度没有明显差异,而液体纳米混悬液在 3 周内是稳定的。与市售片剂相比,包衣丸的溶出速率显著提高。同样,在 Beagle 犬中,基于纳米混悬液的丸芯的 Cmax 和 AUC(0→24)分别是市售片剂的 2.40 倍和 1.66 倍。本研究为稳定纳米混悬液产品、提高难溶性药物的溶出速度和生物利用度提供了一种可靠的方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验